Low-dose CT screening for lung cancer is recommended for certain individuals, but two new studies highlight some of the limitations and growing pains of a screening program.
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis.
An existing body of literature shows that marital status and related social support are connected with disease outcomes.
A laboratory study found that combining anti-HER2 TKIs with trastuzumab and pertuzumab can result in enhanced anticancer activity in HER2+ breast cancer cell lines.
Internal mammary chain radiation therapy for breast cancer is associated with increased cardiac toxicity, in particular when paired with anthracyclines.
Many breast cancer patients report that clinicians do not engage adequately regarding management of financial toxicity associated with their diagnosis, according to a new survey.
The addition of bevacizumab to adjuvant chemotherapy regimens does not improve survival in women with high-risk breast cancer.
A set of reproducible biomarkers are associated with better response rates to anti–PD-1 therapy in patients with advanced melanoma.
A rapid EGFR-specific assay allowed for quicker identification of EGFR mutation–positive NSCLC, and thus a shorter time to initiation of EGFR-directed therapy.
The intratumoral vasculature of high-grade serous ovarian cancer does not appear to undergo significant changes during disease progression.